Skip to content
Single Family OfficePuts its own capital into companiesLAST VERIFIED Oct 2026 · 8 SOURCES

Innova Partnerships

Small boutique family office in Perthshire, Scotland (est. 2006) backing early-stage life-science, active-lifestyle and planet-focused companies, many university spin-outs.

USEFUL FOR Founders · Co-investors

Family & background

HEADQUARTERS
Perthshire, United Kingdom
FOUNDED
2006

Investment approach

GEOGRAPHY
United Kingdom
STAGES
Seed
ROUTES
Companies (own capital)
STRATEGIES
Direct investmentsVenture capital

Overview

Innova Partnerships describes itself as a small boutique family office based in Perthshire, Scotland, investing around healthcare, active lifestyles and the planet. Founded in 2006 to help early-stage life-science businesses, it spun out ventures from UK universities and larger corporates and says it has helped set up well over a dozen start-ups. Since 2017 it has focused on supporting portfolio companies to exit; listed exits include Innova Biosciences (to Expedeon, 2017) and Expedeon (to Abcam). In 2023 it led the management buyout of Novarum Dx from BBI Solutions and backed Penrhos Bio's £3m Series A.

Holdings & investments (19)

People

  • Steven Howell
    Founder and Managing Director; Director · source
  • Andrew McNair
    Director · source
  • Jilly Huggins
    Family Office Manager and Trustee · source

Frequently asked questions

Innova Partnerships is a single family office based in Perthshire, the United Kingdom, founded in 2006.

Innova Partnerships invests its own capital into companies. Its stated asset mix includes direct investments and venture capital.

Innova Partnerships invests at Seed stage in HealthTech, Biotech & Life Sciences, Climate & Energy and Food & Agriculture.

Key people at Innova Partnerships include Steven Howell (Founder and Managing Director; Director), Andrew McNair (Director) and Jilly Huggins (Family Office Manager and Trustee).

Innova Partnerships's holdings and investments include Abbio, Antibody Analytics, Aureum Diagnostics, Cellexus International, Creonate Manufacturing, Dxcover, Novarum Dx and Relaymed, among others.

The most recent publicly reported investment by Innova Partnerships is Penrhos Bio (Series A), announced in Oct 2023.